april trough slightli better expect ziosuit
home enrol mix move evid
recoveri futur opportun telemedicin
reimburs product data catalyst rise keep us
quarter deliv revenu vs mse ahead
pre-announce expect repres
estim see ration initi prove effect opex
total vs mse irhythm busi less acut tie access
pressur benefit telehealth home registr
discuss pre-announce note howev insul partial
attribut dynam revenu lag implant day length
zio wear minim impact back half march
demand pressur may less pronounc expect zio seen
increas relat demand hospit use
outpati set free inpati hospit bed inpati set
respons constrain telemetri bed capac april zio registr rate
level base estim
normal favor level
previous model note dynam could drive longer term
irhythm continu leverag cloud-bas portal ziosuit
ramp home enrol mix showcas nearli ident
perform metric degrad wear time home versu in-
time creat barrier entri competitor improv
workflow physician allow rep spend time expans
account mainten
increas in-hospit demand coupl acceler util
ziosuit potenti propel irhythm new care set vertic
medic technolog unit state america
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
neurolog gener medicin primari care
telemedicin mix like fall level recoveri open new
avenu busi long-term may verili consum implic
like perman part mix
fine-tun model make slight upward revenu adjust
y/i growth remain quarter
project revenu stand
normal slightli increas oper burn
reflect payment tie continu develop verili
collabor exhibit detail key model chang
catalyst line-up juli releas propos rate remain key catalyst
manag commentari suggest chang degre confid
outcom analysi code set suggest rvu tie one set
code day perhap lower set day
perhap flat believ major xt patch fall
second code set continu confid neutral favor
reimburs outcom stem societi support signific clinic data
favor zio greater work valu inher platform time
continu expect screen-af mstop data come
verili commerci expect track
attract phase recoveri phase recoveri model group coverag
three phase phase includ supplier insul posit off-set
busi phase includ tradit implant phase includ
discretionari implant capit intens busi view irhythm
attract phase recoveri stori preval telehealth rise in-
hospit demand bolster recoveri core thesi continu support
mount barrier entri given irhythm enterprise-wid suit solut
continu sale momentum xt well roll-out drive cross-
sell xt account expans catalyst discuss pt
irhythm zio pois disrupt
technolog larg grow market
ambulatori electrocardiogram monitor
us better diagnost yield cost
irhythm success penetr
exist ecg monitor market
multipl catalyst total address
market expans new product
launch indic expans effort
view descript risk reward theme
disrupt technolog grow end market expans potenti
price target support dcf reect multipl base
case sale assum sale growth driven continu zio penetr
irhythm see faster market penetr
addit upsid new indic ex
us expans stronger zio traction due
increas sale forc efcienc robust
insur coverag reimburs
push investor valu busi
higher multipl line peer group
impact less sever peer
on-line enrol registr
irhythm abl reach low doubl digit
penetr us ambulatori ecg
market drive sale
impact zio volum
materi expect irhythm face
slower launch tougher competit
reimburs outcom turn
unfavor scenario us market
share reach high singl digit
end valuat multipl contract
investor appli multipl discount
peer group
irhythm current penetr us
ambulatori ecg monitor market
physician dilig suggest potenti
util doubl
extens databas ecg data curat
abil provid data qualiti cost
faster expect scale zio roll-out
drive meaning share gain near term
faster expect protabl break-even
competitor on-going effort develop
limit visibl manag effort
introduct indic expans effort
on-going invest may lead futur
view explan region hierarchi
research highest favor quintil
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
financi exhibit
million except ep
sale
sale
sale
sale
invest
st debt current portion lt debt
treasuri
amort debt discount issuanc
amort accret invest
loss dispos asset
chang accru interest
chang allow doubt account
chang fair valu warrant liabil
chang fair valu deriv liabil
net chang work capit
purchas invest
sale invest
net invest
chg short-term debt
chg long-term debt
payment defer offer cost
chang equiti
effect exchang rate chang
net financ
begin period
end period
